Saudi Vision 2030 & Healthcare Transformation
What is Vision 2030?
Saudi Vision 2030 is the Kingdom of Saudi Arabia's national strategic framework, announced by Crown Prince Mohammed bin Salman in 2016, to reduce dependence on oil, diversify the economy, and develop public service sectors including healthcare, education, and infrastructure.
Healthcare transformation is one of the flagship pillars of Vision 2030, with ambitious targets to improve healthcare quality, expand access, and establish Saudi Arabia as a regional medical hub.
Vision 2030 healthcare goals
Key healthcare targets under Vision 2030 include:
- Privatisation of healthcare — transitioning hospitals and clinics from government to private sector operation; increasing private sector's share of healthcare delivery
- Digital health — building a national digital health infrastructure, expanding telemedicine, and deploying AI-enabled clinical tools
- Local manufacturing — incentivising medical device and pharmaceutical manufacturing within Saudi Arabia (reducing import dependence)
- Medical tourism — attracting international patients for specialised treatment
- Workforce nationalisation (Saudisation) — increasing Saudi national participation in healthcare professions
- Preventive health — reducing the burden of non-communicable diseases (diabetes, obesity, cardiovascular disease)
Implications for medical device manufacturers
Vision 2030 creates both opportunities and regulatory context for medical device companies:
Growing market
Saudi Arabia's medical device market was valued at over USD 2.1 billion in 2023 and is forecast to grow significantly. Healthcare expansion — new hospitals, clinics, primary care centres — drives demand for devices across all categories.
Digital health opportunity
The government's investment in digital health infrastructure creates demand for:
- AI-enabled diagnostic imaging
- Remote patient monitoring systems
- Electronic health record-integrated devices
- Point-of-care diagnostics for primary and preventive care
Local manufacturing incentives
Vision 2030 includes incentives for companies that manufacture locally in Saudi Arabia, including preferential procurement consideration in government tender processes. Manufacturers considering in-Kingdom production can benefit from these programmes.
Regulatory modernisation
The SFDA's own regulatory modernisation — including the new Medical Devices Law (2021), GHAD portal, UDI requirements, and IMDRF alignment — is partly driven by Vision 2030's goal of aligning Saudi Arabia with international best practice and attracting foreign investment.
GCC hub strategy
Saudi Arabia aims to position itself as the regulatory and commercial hub for the broader GCC medical device market. Registration in Saudi Arabia is increasingly seen as the foundation of a GCC-wide market access strategy.
Saudi Health Council and NUPCO
Two additional entities relevant to medical device market access under Vision 2030:
- Saudi Health Council — coordinates health policy and hospital procurement standards
- NUPCO (National Unified Procurement Company) — the government entity managing centralised procurement for government hospitals; MDMA registration is a prerequisite for NUPCO tender participation